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OBJECTIVE:  Exploding head syndrome (EHS) is a benign sensory parasomnia characterized 
by the perception of loud noises or a sense of explosion in the head. Few studies have assessed 
clinical features and little is known about demographic differences or prevention strategies. 
PATIENTS/METHODS: A cross-sectional study of 3286 individuals with and 2954 without 
lifetime EHS episodes was conducted via online questionnaires.  
RESULTS:  Those with EHS had shorter sleep durations, longer sleep onset latencies, poorer 
sleep quality, and less sleep efficiency, but effect sizes for these differences were small. Females 
were slightly more likely than males to endorse EHS. 44.4% of individuals with EHS 
experienced significant fear during episodes, but fewer reported clinically significant distress 
(25.0%) or interference (10.1%) as a result of EHS. Most sufferers believed it to be a brain-based 
phenomenon, but a small minority endorsed anomalous causes. Five prevention strategies with 
>50% reported effectiveness were identified.   
CONCLUSIONS:  EHS was assessed in the largest sample to date.  Though associated with 
clinical impacts, no empirically supported interventions yet exist. The five prevention strategies 
may prove useful for treatment development. 
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1. Introduction   
Exploding head syndrome (EHS), alternately termed “episodic cranial sensory shocks”, is 
a sensory parasomnia characterized by perceptions of either a loud noise or sense of explosion in 
one’s head during sleep transitions [1,2]. These episodes are associated with abrupt arousal but 
are not accompanied by significant pain. However, headache disorders and other conditions 
remain important considerations for differential diagnosis [3].  
Though first documented in the 1800’s, EHS received scant attention until the 1980s 
[e.g., 3,4]. This is despite its relative commonality and clinical importance. For example, lifetime 
episode prevalence rates range between 10% and 37% [e.g., 5-7]. EHS episodes can be upsetting, 
with average fear levels above moderate [7]. However, only a minority of people with a history 
of EHS experience clinically significant distress and/or impairment [7]. For these individuals, 
well-established treatment options are not available and it is currently unknown if behavioral or 
psychological procedures may help prevent episodes. One study found that a relatively small 
percentage of EHS sufferers (8.51%) made active attempts to prevent episodes through altering 
their sleep patterns or using hypnotics [8]. Unfortunately, the limited sample size (N = 47) 
precluded a substantive determination of the relative effectiveness of these methods. Regardless, 
a small evidence base is accruing on the correlates and associated features of EHS which may 
prove useful for developing interventions. Indeed, insomnia, life stress, anxiety, symptoms of 
depression, sleep position, and the presence of other sleep experiences (e.g., isolated sleep 
paralysis) have all been associated with EHS [5,7,8].   
Basic questions about EHS remain. For example, differences in prevalence rates across 
groups have not yet been determined (e.g., sex differences) [1,3,5,7]. There are also unanswered 





there are clinical reports that some sufferers attribute EHS to non-biological, anomalous causes 
(e.g., electromagnetic disturbances and/or use of directed energy weapons; [9]), but the actual 
prevalence of such beliefs is unknown.   
The present study attempts to clarify these matters using an online questionnaire and the 
largest sample to date of participants reporting EHS.  The purposes are to: 
• Assess for differences in EHS prevalence according to demographics; 
• Determine frequency, fear level, and overall clinical distress and interference associated 
with EHS episodes; 
• Replicate associations between sleep disturbances and EHS; 
• Catalogue the perceived etiologies of EHS; 
• Catalogue attempts taken to prevent EHS episodes and their perceived effectiveness. 
2. Methods 
2.1. Procedure 
 The study was initiated by the British Broadcasting Corporation’s (BBC) Science Focus 
Magazine and was publicized through that publication, popular press interviews with study 
authors (BAS, CCF, and AMG), and social media. Ethical approval was granted through 
Goldsmiths, University of London. Participation was restricted to those who agreed to the terms 
of the study, provided informed consent, and were at least 18 years old. UK nationals were 
permitted to enter a prize draw to receive gift cards. 
2.2. Questionnaire Items 
Sleep quality and efficiency were measured using the first four items of the well-
validated and reliable Pittsburgh Sleep Quality Index (PSQI) [10]. Severity of insomnia 





Index (ISI) [11], with the first three items collapsed into one. EHS was assessed using 11 items 
adapted from the Exploding Head Syndrome Interview (EHSI) [7], which assesses EHS 
symptoms using International Classification of Sleep Disorders – Third Edition criteria [1], 
inquires into perceived etiologies, and includes questions relevant for differential diagnosis. See 
Appendix A for further item information.  
2.3. Qualitative Data 
Participants were asked if they attempted to prevent EHS episodes and could list up to 
four prevention strategies and rate their perceived effectiveness (0-100%). Responses were coded 
using conventional content analysis without preconceived categories [12] as well as a priori 
consensus procedures [13]. This process was repeated to explore sub-themes. Coding was 
conducted by one postgraduate and five undergraduate raters trained and supervised by a 
psychology researcher (RP) experienced in qualitative procedures. Interrater agreement was 
good (Kappa = .81). In order to maintain independence of observations (i.e., to preclude the 
possibility that multiple responses from the same person were analyzed as belonging to a single 
strategy – hence skewing results), qualitative data were analyzed separately for each response 
given (i.e., whether the first, second, third or fourth response). Single responses that were coded 
as reflecting multiple prevention strategies were excluded. 
2.4. Notes on Analyses 
Non-parametric analyses were used when parametric assumptions were violated. As the 
removal of outliers did not alter any results as per sensitivity analyses (available upon request), 
the entire available sample was utilized for all analyses.  
3. Results 





Figure 1 displays participant flow and exclusions. The final number of participants 
reporting at least one EHS episode was 3286 (52.7%).  Participants classified themselves as 
White (92.3%), mixed ethnicity (2.7%), Asian (2.0%), or prefer not to say (1.0%), with the 
remaining Black, Arab, Roma, or “other”. The sample was primarily female (66.0%) with a 
mean age of 47.0 (SD = 15.3; range = 18-89). 
3.2. Demographic Differences 
Minorities were not more likely to experience EHS than Whites (p = .12). Contrary to 
some recent studies [e.g., 5,7], but consistent with earlier reviews [3,14], women were 
marginally more likely to endorse EHS than men (53.5% vs 50.7%; X2(1, N = 6186) = 4.47, p = 
.036, φ = .027). Participants with EHS (M = 46.0 years; SD = 14.8) were slightly younger than 
those without (M = 48.1; SD = 15.8), (U = 4468351.00, p < .001, r = .07). 
3.3. EHS Frequency, Fear, Distress, and Impairment 
 EHS distributions can be found in Figure 2. Supplemental analyses indicated that 
increased frequency of episodes was associated with higher distress (rs(3267) = .167, p < .001) 
and greater impairment (rs(3259) = .321, p < .001) resulting from episodes. 
3.4. Sleep and EHS 
Considering sleep quality, participants with EHS reported longer sleep onset latencies (M 
= 30.3 minutes) over the past month than those without (M = 25.3 minutes) (U = 2882454.50, p 
< .001, r = .11). Similarly, sleep duration was shorter for those with EHS (M = 6:49:01, SD = 
1:08:42) than without (M = 6:55:31, SD = 1:08:25, F(1, 5467) = 12.21, p <.001, partial η2 = 
.002). Of note, the overall sample’s sleep duration was brief overall (M = 6:52:06, SD = 1:08:38), 





(M = 84.1%, SD = 12.7) than those without (M = 84.9%, SD = 12.6%, F(1, 5404) = 5.815, p = 
.016, partial η2 = .001).  
The three ISI items were summed to assess insomnia symptoms (Cronbach’s alpha = 
.89). ISI total was higher for those with EHS (M = 8.4 SD = 2.9) than without (M = 7.6, SD = 
3.0; F(1, 6203) = 117.78, p <.001, partial η2 = .019). 
3.5. Self-Reported Etiologies  
 99.6% (N = 3273) of those reporting EHS answered questions about etiology. The most 
frequently endorsed causes were: “something in the brain” (N = 1982; 60.6%), “stress” (N = 
1136; 34.7%), “medication side effects” (N = 235; 7.2%), “something supernatural” (N = 92; 
2.8%), and “electronic equipment” (N = 75; 2.3%). Participants could endorse multiple causes. 
3.6. Prevention Strategies 
The six most common prevention strategies and perceived effectiveness ratings are found 
in Table 1. All except the last had mean ratings above 50%. An attempted internal replication of 
these findings (using responses 2 and 3; prevention strategies in response four had n ≤ 4 and are 
therefore not reported) can be found in Appendix B. The three most common strategies using the 
second response were among those identified using the first response, but there was some 
variability in the perceived effectiveness ratings (e.g., although adjusting sleep patterns/reducing 
tiredness replicated, mindfulness/breathing techniques did not). 
4. Discussion 
EHS episodes and their sequelae were assessed in the largest sample to date. Participants 
reporting EHS displayed only minor differences compared to those without. Specifically, EHS 





differences were likely not clinically meaningful (i.e., all effect sizes = small or below).  Women 
were marginally more likely to report EHS, but this effect size was also quite small.  
EHS was associated with negative clinical impacts. 44.4% reported clinically significant 
(i.e., moderate or above) levels of fear during EHS episodes. Fewer reported clinically 
significant levels of distress (25.5%) or impairment (10.1%) as a result of episodes, but this risk 
increased with episode frequency. A small percentage reported anomalous etiologies for EHS as 
well. Future work should examine how common this is in other medical sensory phenomena, as 
it may not be specific to EHS. Analysis of open-ended responses yielded five strategies reported 
to be effective in preventing EHS. These were consistent with an earlier report [8], displayed 
overlap with existing insomnia treatments [15-16], and may prove useful for developing 
effective interventions. Finally, as use of the EHS screener question alone yielded 12.0% false 
positives, it is recommended that researchers and clinicians include additional assessment items 
(esp., inquiries into pain). 
4.1. Limitations 
• EHS was not assessed via clinical interview. 
• The sample was self-selected as indicated by a high percentage of participants reporting 
EHS and low overall sleep duration. Methods of advertisement may have led to an 
overrepresentation of sleep disturbances. Accordingly, our findings of minor group 
differences warrant additional research.  
• Sub-themes identified in the qualitative analysis had relatively small sample sizes and 







Highlights (85 characters max) 
• EHS is associated with marginally poorer/shorter sleep 
• EHS is often associated with clinically significant fear during episodes 
• EHS can be associated with clinically significant distress and/or impairment 
• EHS screeners without additional questions (e.g., pain) can lead to false positives 
• Some EHS sufferers may hold unfounded anomalous beliefs about its etiology  
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